Coronavirus And Schools, New Mars Rover. July 17, 2020, Part 1
Science Friday
Science Friday and WNYC Studios
4.4 • 6.3K Ratings
🗓️ 17 July 2020
⏱️ 47 minutes
🧾️ Download transcript
Summary
Transcript
Click on a timestamp to play from that location
| 0:00.0 | This is Science Friday. I'm Ira Plato. A bit later in the hour, we're going to talk about |
| 0:06.0 | back to school, what it might look like for K-12 students this fall. Some districts are |
| 0:11.8 | releasing their plans, and they all look a little bit different. But first, one big question about |
| 0:17.5 | this pandemic is how long will it take to develop a COVID-19 vaccine? |
| 0:22.9 | There are lots of candidates and clinical trials happening. |
| 0:26.6 | The National Institutes of Health is running a trial created by the company Moderna. |
| 0:31.5 | The results were published this week in the New England Journal of Medicine. |
| 0:35.2 | Here to give us an update on that vaccine trial and |
| 0:38.4 | other science headlines from the week is Annalie Newitz, science writer and author based out |
| 0:43.6 | of San Francisco. Welcome back. Hey, thanks for having me. Nice to have you. This vaccine has been |
| 0:49.6 | tested in people and passed through phase one trial. So please, tell us what that means. So what that means |
| 0:56.3 | is that the vaccine was tested on a small group. In this case, it was 45 people of different ages. |
| 1:02.8 | And it showed that it is not only safe, it's not causing any disastrous side effects, but it's also |
| 1:09.6 | efficacious. It's creating antibodies in the |
| 1:13.8 | people who have taken it. So that means that Moderna is hoping to quickly move into a phase three |
| 1:21.8 | trial. And that means that it'll be a much bigger trial on lots of people and hoping to find out that it |
| 1:29.9 | works once we have a bigger population taking it. |
| 1:33.9 | Are they skipping phase two going right to phase three? |
| 1:38.0 | So oftentimes phase one and two get kind of squished together. |
| 1:43.4 | And so what we're seeing here is a speeded up version of |
| 1:47.9 | a typical set of trials. So phase one and two are designed to determine, as I said, safety and |
| 1:55.6 | efficaciousness. And so now in phase three, we try to see how it fares in a big population. They're hoping to have that |
... |
Please login to see the full transcript.
Disclaimer: The podcast and artwork embedded on this page are from Science Friday and WNYC Studios, and are the property of its owner and not affiliated with or endorsed by Tapesearch.
Generated transcripts are the property of Science Friday and WNYC Studios and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.
Copyright © Tapesearch 2026.

